Amphastar Pharmaceuticals filed required 13F reports with the SEC on June 6, 2026.
1 report, 1 independent
Updated Jun 6
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Amphastar Pharmaceuticals filed required 13F reports with the SEC on June 6, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Amphastar Pharmaceuticals
publicly traded American pharmaceutical company
Nothing else this week.
-
Securities and Exchange Commission
government agency of the Philippines
Related events
- LiveRamp filed its required 13F reports with the Securities and Exchange Commission.
- Humana filed its required 13F reports with the Securities and Exchange Commission on September 3, 2026.
- Reliance, Inc. was required to file its 13F reports with the Securities and Exchange Commission.
- RPM International filed its required Form 13F filings with the Securities and Exchange Commission on August 17, 2026.
- Bristol-Myers Squibb filed Form 13F with the Securities and Exchange Commission on August 25, 2026.